BZNE Stock | News | Quote | Stock Forum | Wednesday, October

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Biozone Pharmaceuticals, Inc. BZNE Company Overview 

Stock Message Board http://investorshangout.com/search?q=BZNE&...mp;yt1=Go!

Last Updated: Wednesday, October 23, 2013 7:13:13 PM

Biozone Pharmaceuticals, Inc. BZNE Current Price and Quotes
Last Price 0.675
Previous Close 0.68 Open 0.68
Daily Range 0.695 - 0.62 52wk Range 3.75 - 0.16
Volume 1,118,133 Dividend N/A
Average Vol (3m) 1,478,820 Yield N/A
Biozone Pharmaceuticals, Inc. BZNE
Company Information

550 Sylvan Avenue
Suite 101
Englewood Cliffs, NJ 07632

Phone: 201-608-5101

Biozone Pharmaceuticals, Inc. BZNE
Biozone Pharmaceuticals, Inc. BZNE
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001412486
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Dec 31, 0007
Incorporated In: NV, USA
Year of Inc. 2006
Employees Not Available
Company Officers/Contacts

Elliot Maza Interim CEO, CFO
Roberto Prego Novo President, Principal Acct. Officer
Company Directors

Roberto Prego Novo
Company Notes

Formerly=International Surf Resorts, Inc. until 3-2011
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
M2 Law Professional Corp.
500 Newport Center Dr.
Newport Beach, CA, 92660
United States

Investor Relations Firm
Not Available

Biozone Pharmaceuticals, Inc. BZNE
BZNE Security Details

Share Structure

Market Value1 $47,335,701 a/o Oct 22, 2013
Shares Outstanding 69,611,325 a/o Jul 31, 2013
Float Not Available
Authorized Shares Not Available
Par Value  0.001
Shareholders

Shareholders of Record 257 a/o Apr 01, 2013
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.00) Mar 15, 2011 Mar 11, 2011 Mar 14, 2011
Security Notes

Capital Change=shs increased by 10 for 1 split. Ex-date=03/15/2011. Rec date=03/11/2011. Pay date=03/14/2011.
Short Selling Data

Short Interest 126 (-93.37%)
Sep 30, 2013
Significant Failures to Deliver Yes - Reg SHO
Transfer Agent(s)



Biozone Pharmaceuticals, Inc. BZNE Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 17,191 12,605 15,254 -
Cost of Revenue 9,969 9,920 8,428 -
Gross Profit 7,222 2,686 6,826 -
Operating Expenses

Research and Development 743 423 241 -
Sales, General and Admin. 9,115 6,149 6,617 9
Non-Recurring Items - - - 34
Other - - - -
Operating Income (2,637) (3,887) (32) (43)
Income From Continuing Operations

Add'l Income/Expense Items 154 (282) - -
Earnings Before Interest and Tax (2,483) (4,211) 23 (43)
Interest Expense 5,482 1,243 439 -
Earnings Before Tax (7,965) (5,454) (416) (43)
Income Tax - 3 (96) -
Minority Interest - - - (1)
Equity Earnings Unconsolidated Subsidiary - (43) 55 -
Net Income Cont. Operations (7,965) (5,500) (265) (41)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (7,965) (5,457) (320) (41)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (7,965) (5,457) (320) (41)

Biozone Pharmaceuticals, Inc. BZNE Recent News

BZNE Biozone Pharmaceuticals, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=BZNE&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/BZNE/quote
Stock Chart http://www.otcmarkets.com/stock/BZNE/chart
Company Info http://www.otcmarkets.com/stock/BZNE/company-info
Recent News http://www.otcmarkets.com/stock/BZNE/news
Financials http://www.otcmarkets.com/stock/BZNE/financials
Filings and Disclosure http://www.otcmarkets.com/stock/BZNE/filings
Short Sales http://www.otcmarkets.com/stock/BZNE/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/BZNE/insider-transactions
Research Reports http://www.otcmarkets.com/stock/BZNE/research
Summary http://finance.yahoo.com/q?s=BZNE
Historical Prices http://finance.yahoo.com/q/hp?s=BZNE+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=BZNE
Basic Chart http://finance.yahoo.com/q/bc?s=BZNE+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BZNE+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=BZNE+Headlines
Press Releases http://finance.yahoo.com/q/p?s=BZNE+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=BZNE+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=BZNE+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=BZNE+Industry
Major Holders http://finance.yahoo.com/q/mh?s=BZNE+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=BZNE+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=BZNE+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=BZNE
Balance Sheet http://finance.yahoo.com/q/bs?s=BZNE
Cash Flow http://finance.yahoo.com/q/cf?s=BZNE+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/BZNE
Market Watch http://www.marketwatch.com/investing/stock/BZNE
Bloomberg http://www.bloomberg.com/quote/BZNE:US
Morningstar http://quotes.morningstar.com/stock/s?t=BZNE
Bussinessweek http://investing.businessweek.com/research/st...icker=BZNE
Barchart http://www.barchart.com/quotes/stocks/BZNE
OTC Short Report http://otcshortreport.com/index.php?index=BZNE
Investopedia http://www.investopedia.com/markets/stocks/BZNE/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

APP Group's New Conservation Efforts in Sumatra

Updated Category News Views 215

Taking a Bold Step Towards Conservation APP Group, in collaboration with Proforest, WWF-Indonesia, and KKI WARSI, is setting its sights on a more sustainable future with the PROTECT30 initiative. This isn't just another dime-a-dozen CSR project—it’s a concerted effort aimed at conserving Sumatra's precious Bukit Tigapuluh landscape. These folks are playing the long...

Continue Reading
Sussex County Data Breach Raises Security Concerns

Updated Category News Views 136

The Digital Fiasco: A Wake-Up Call Straight out of Sussex County in good ol' New Jersey, we’re staring down another data breach, folks. When you hear about a data privacy incident, there's always that same sinking feeling of another layer of personal security peeled away. This time, the Sussex County Prosecutor's Office got caught in the crossfire, with personal info...

Continue Reading
Future FinTech Under Investigation: Shareholder Impact Looms

Updated Category News Views 81

Future FinTech Faces Legal Scrutiny When the walls close in under financial suspicion, the spotlight can burn brighter than any anticipated market gain. That's precisely what Future FinTech Group Inc. (NasdaqCM: FTFT) is up against now. Kahn Swick & Foti, LLC, featuring the ex-Attorney General of Louisiana, Charles C. Foti, Jr., has begun scrutinizing the actions of...

Continue Reading
New Frontiers in Glaucoma Care: Less Drops Required?

Updated Category News Views 88

Eyeing New Glaucoma Treatment Strategies You think glaucoma treatment is all about popping eye drops day in and day out? Well, turns out, things are shifting down in Racine, Wisconsin. Folks at HelloNation have been spilling the beans on earlier glaucoma interventions that might just lighten your load of daily medications. Doctors I. Paul Singh and R. Krishna Sanka...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 143

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 77

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
212NYC Gala Celebrates Ad Industry's Human Touch

Updated Category News Views 208

The Advertising Gala with Heart When you toss nearly 300 advertising honchos into a room at Tribeca's Rooftop, you don't just get another bash; you get an industry checkpoint. This time, the 212NYC shindig on November 5, 2026, wasn't just about stroking egos. It was about spotlighting the soul in business, right when AI threatens to run wild with it. Navigating AI's...

Continue Reading
Madrigal Faces Legal Scrutiny Amid Whistleblower Claims

Updated Category News Views 204

The Storm Brewing Over Madrigal Pharmaceuticals Well, folks, here we are smack dab in the middle of another roller-coaster ride in the biotech sector, and it ain't pretty. Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is in hot water with some serious allegations thrown their way. The company is now under investigation by Kessler Topaz Meltzer & Check, LLP, a top-notch...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 63

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 76

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading

Top 5 Most Recently Viewed Articles

Pedro Langa Takes the Helm as Indigo Ag's New CFO

Updated Category News Views 351

Pedro Langa Appointed Chief Financial Officer at Indigo Ag Indigo Ag has named Pedro Langa as its new Chief Financial Officer, effective immediately. This decision follows an extensive recruitment process that aimed to find the best fit for this vital role. Langa comes with over two decades of experience in finance across various sectors, particularly in food and...

Continue Reading
Vuzix Corporation Achieves Historic Milestone with VUZI Stock

Updated Category News Views 304

Vuzix Corporation Stocks Hit New Heights Vuzix Corporation (NASDAQ: VUZI) has recently made headlines by reaching a remarkable 52-week high, peaking at $3.97. This achievement signals a strong market confidence in the company, as the stock has realized an impressive 188.72% return over the past six months. Despite the surge, it remains crucial to navigate the analysis...

Continue Reading
Dogecoin Rises as Bitcoin Stabilizes; Analysts Eye $90K Soon

Updated Category News Views 189

Bitcoin's Roller Coaster and Dogecoin's Surge The cryptocurrency market is always buzzing, and recently, Bitcoin has paused its rally, attracting significant interest as it hovers just above $67,000. The king of meme coins, Dogecoin, on the other hand, has seen a remarkable rise, with its value increasing over 7% in a single day. Recent Performance of Major...

Continue Reading
Nokia Corporation's Significant Share Repurchase Initiative

Updated Category News Views 140

Nokia Corporation's Strategic Share Repurchase Plan Nokia Corporation is taking bold steps to strengthen its market position and boost shareholder value through a proactive share repurchase program. This initiative signifies Nokia's commitment to managing its stock efficiently while providing returns to its investors. Details of the Share Repurchase Recently, Nokia...

Continue Reading
Innovative Investment Fuels Okika Devices' Future Growth Strategy

Updated Category News Views 222

Strategic Investment Boosts Okika Devices Advancement Colorado ONE Fund, which is part of the ONE Funds initiative, has made a major investment in Okika Devices, a company recognized for its innovation in Field Programmable Analog Array (FPAA) technology. This investment aligns with Colorado ONE Fund's mission to support technologies that advance the local innovation...

Continue Reading